Louisiana § 40:1103.3 Standard written summary of breast cancer alternatives

Louisiana Statutes

§ 40:1103.3 — Standard written summary of breast cancer alternatives

Louisiana § 40:1103.3

Title 40Public Health and Safety

This text of Louisiana § 40:1103.3 (Standard written summary of breast cancer alternatives) is published on Counsel Stack Legal Research, covering Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

La. Stat. Ann. § 40:1103.3 (2026).

Text

§1103.3. Standard written summary of breast cancer alternatives

A.Pursuant to the provisions of this Part and no later than March 1, 2000, the department, in consultation with the Louisiana Cancer Advisory Board, shall develop a standard written summary of the advantages, disadvantages, risks, and descriptions of the procedures regarding medically viable and efficacious alternative methods of treatment for breast cancer including surgical, radiological, or chemotherapeutic treatments or combinations thereof. Thereafter, the department shall review and, if necessary, revise the summary every three years; however, the department shall revise the summary prior to the three-year review if the department determines that new or revised information should be included in the summary.

B.At a mini

Free access — add to your briefcase to read the full text and ask questions with AI

§1103.3. Standard written summary of breast cancer alternatives
A. Pursuant to the provisions of this Part and no later than March 1, 2000, the
department, in consultation with the Louisiana Cancer Advisory Board, shall develop a
standard written summary of the advantages, disadvantages, risks, and descriptions of the
procedures regarding medically viable and efficacious alternative methods of treatment for
breast cancer including surgical, radiological, or chemotherapeutic treatments or
combinations thereof. Thereafter, the department shall review and, if necessary, revise the
summary every three years; however, the department shall revise the summary prior to the
three-year review if the department determines that new or revised information should be
included in the summary.
B. At a minimum, the summary shall incorporate all of the following:
(1) Information regarding any method of treatment for breast cancer that is in the
investigational or clinical trial stage and is recognized for treatment by the Physician's Data
Query of the National Cancer Institute.
(2) Available telephone numbers, including but not limited to, toll-free numbers for
the National Cancer Institute and the American Cancer Society, to allow a breast cancer
patient to obtain current information.
(3) A discussion of breast cancer reconstruction surgery, including but not limited
to problems, benefits, and alternatives.
(4) Statistics on the incidence of breast cancer.
C.(1) The summary shall be developed using layman's terminology and shall be
written in generally understandable language.
(2) The board shall have the summary printed and the printed copies made available
to physicians and surgeons upon their request. Furthermore, the board shall establish a
distribution system for the summary that is linked to the renewal of a physician's license.